These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 25091681)
1. Rotavirus gastroenteritis in India, 2011-2013: revised estimates of disease burden and potential impact of vaccines. John J; Sarkar R; Muliyil J; Bhandari N; Bhan MK; Kang G Vaccine; 2014 Aug; 32 Suppl 1():A5-9. PubMed ID: 25091681 [TBL] [Abstract][Full Text] [Related]
2. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Milne RJ; Grimwood K Value Health; 2009 Sep; 12(6):888-98. PubMed ID: 19490550 [TBL] [Abstract][Full Text] [Related]
3. Disease and economic burden of rotavirus diarrhoea in India. Tate JE; Chitambar S; Esposito DH; Sarkar R; Gladstone B; Ramani S; Raghava MV; Sowmyanarayanan TV; Gandhe S; Arora R; Parashar UD; Kang G Vaccine; 2009 Nov; 27 Suppl 5():F18-24. PubMed ID: 19931713 [TBL] [Abstract][Full Text] [Related]
4. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil. Fernandes EG; Sato HK; Leshem E; Flannery B; Konstantyner TC; Veras MA; Patel MM Vaccine; 2014 Jun; 32(27):3402-8. PubMed ID: 24736002 [TBL] [Abstract][Full Text] [Related]
5. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program. Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778 [TBL] [Abstract][Full Text] [Related]
6. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Payne DC; Staat MA; Edwards KM; Szilagyi PG; Gentsch JR; Stockman LJ; Curns AT; Griffin M; Weinberg GA; Hall CB; Fairbrother G; Alexander J; Parashar UD Pediatrics; 2008 Dec; 122(6):1235-43. PubMed ID: 19047240 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of rotavirus vaccination programs in Taiwan. Chang WC; Yen C; Chi CL; Wu FT; Huang YC; Lin JS; Huang FC; Tate JE; Wu HS; Hsiung CA Vaccine; 2013 Nov; 31(46):5458-65. PubMed ID: 24060569 [TBL] [Abstract][Full Text] [Related]
8. Hospital based surveillance and genetic characterization of rotavirus strains in children (<5 years) with acute gastroenteritis in Kolkata, India, revealed resurgence of G9 and G2 genotypes during 2011-2013. Mullick S; Mandal P; Nayak MK; Ghosh S; De P; Rajendran K; Bhattacharya MK; Mitra U; Ramamurthy T; Kobayashi N; Chawla-Sarkar M Vaccine; 2014 Aug; 32 Suppl 1():A20-8. PubMed ID: 25091674 [TBL] [Abstract][Full Text] [Related]
9. Rotavirus vaccination in central Europe. Mészner Z; Anca I; André F; Chlibek R; Čižman M; Grzesiowski P; Mangarov A; Pokorn M; Prymula R; Richter D; Salman N; Šimurka P; Tamm E; Tešović G; Urbancikova I; Usonis V; Zavadska D; J Pediatr Gastroenterol Nutr; 2013 Jun; 56(6):586-96. PubMed ID: 23708638 [TBL] [Abstract][Full Text] [Related]
10. Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis. Rose J; Homa L; Meropol SB; Debanne SM; Bielefeld R; Hoyen C; Singer ME PLoS One; 2017; 12(11):e0187446. PubMed ID: 29099848 [TBL] [Abstract][Full Text] [Related]
11. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. Tate JE; Rheingans RD; O'Reilly CE; Obonyo B; Burton DC; Tornheim JA; Adazu K; Jaron P; Ochieng B; Kerin T; Calhoun L; Hamel M; Laserson K; Breiman RF; Feikin DR; Mintz ED; Widdowson MA J Infect Dis; 2009 Nov; 200 Suppl 1():S76-84. PubMed ID: 19817618 [TBL] [Abstract][Full Text] [Related]
12. An economic analysis of rotavirus vaccination in Italy. Giammanco MD; Coniglio MA; Pignato S; Giammanco G Vaccine; 2009 Jun; 27(29):3904-11. PubMed ID: 19446934 [TBL] [Abstract][Full Text] [Related]
13. Can routinely collected national data on childhood morbidity and mortality from diarrhea be used to monitor health impact of rotavirus vaccination in Africa? Examination of pre-vaccine baseline data from Rwanda. Ngabo F; Gatera M; Karema C; Donnen P; Lepage P; Parashar UD; Tate JE; Mwenda JM; Rugambwa C; Binagwaho A Pediatr Infect Dis J; 2014 Jan; 33 Suppl 1():S89-93. PubMed ID: 24343621 [TBL] [Abstract][Full Text] [Related]
14. Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities. Rheingans R; Anderson JD; Anderson B; Chakraborty P; Atherly D; Pindolia D Vaccine; 2014 Aug; 32 Suppl 1():A140-50. PubMed ID: 25091669 [TBL] [Abstract][Full Text] [Related]
15. Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States. Flores AR; Szilagyi PG; Auinger P; Fisher SG Pediatrics; 2010 Feb; 125(2):e191-8. PubMed ID: 20100749 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of a pentavalent rotavirus vaccine in Japan. Itzler R; O'Brien MA; Yamabe K; Abe M; Dhankhar P J Med Econ; 2013 Oct; 16(10):1216-27. PubMed ID: 23919721 [TBL] [Abstract][Full Text] [Related]
17. Rotavirus vaccine: a cost effective control measure for India. Kumar A; Goel MK; Jain RB; Khanna P; Vibha V Hum Vaccin Immunother; 2012 Apr; 8(4):501-4. PubMed ID: 23071989 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana. Abbott C; Tiede B; Armah G; Mahmoud A Vaccine; 2012 Mar; 30(15):2582-7. PubMed ID: 22321664 [TBL] [Abstract][Full Text] [Related]
19. Rotavirus vaccines at the threshold of implementation in India. Tate JE; Arora R; Kang G; Parashar UD Natl Med J India; 2014; 27(5):245-8. PubMed ID: 26037421 [TBL] [Abstract][Full Text] [Related]
20. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. Harris JP; Jit M; Cooper D; Edmunds WJ Vaccine; 2007 May; 25(20):3962-70. PubMed ID: 17395343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]